- Research Grants
Dr. Rozenchan has 18 years of academic experience in oncology, mostly in tumor microenvironment field, with prior roles included Cell Therapy Laboratory Research Chief at Colsan from 2012 to 2016. Dr. Rozenchan has a Ph.D from São Paulo University (USP) in Oncology with post-doctoral in molecular biology from Federal University of São Paulo (UNIFESP) and has recently graduated in cancer biology and therapeutics program, a one year training program from Harvard Medical School. She has conducted research projects at two important Brazilian universities, USP and UNIFESP. Also, she previously served as a consultant for new business in the company since June 2016. Now as our Research & Development Executive Director she leads the manufacturing operations, oversees process development and coordinates research operations more broadly, integrating our pipeline, third generation CAR-T research with clinical outcomes. (Source: Lattes Curriculum)
One of the great challenges of cancer treatments is that at some point the tumor cells may no longer respond to the treatment, or after a certain time free of the disease, the patient may present a recurrence. Thus, there is a great demand for new methods in the treatment of cancer, since the conventional methods of treatment; surgery, radiation and chemotherapy, do not guarantee cure f...
(Only some records are available in English at this moment)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|
(References retrieved automatically from State of São Paulo Research Institutions)
ROZENCHAN, Patricia Bortman. Caracterização molecular de fibroblastos originários de tecido mamário neoplásico ou não e modificação do perfil gênico após interação com células epiteliais mamárias normais. Tese (Doutorado) - Faculdade de Medicina. Universidade de São Paulo (USP). São Paulo. (01/13515-1)